Form 4: DSS, Inc. Reduces Stake in Impact Biomedical Inc.
SEC Form 4
DSS, Inc. reports the sale of Impact Biomedical Inc. shares through multiple transactions, decreasing its direct and indirect holdings.
Summary
- DSS, Inc. has reported changes in its beneficial ownership of Impact Biomedical Inc. common stock.
- On March 21, 2025, DSS, Inc. indirectly disposed of 166,600 shares each through DSS Securities, Inc., DSS BlockChain Security, Inc., at a price of $3.3004 per share.
- On the same date, DSS BioHealth Security, Inc. indirectly disposed of 166,600 shares at $3.3004, leaving it with 1,178,882 shares.
- On March 26, 2025, DSS, Inc. directly disposed of 48,281 shares at $3.1292, resulting in a holding of 1,109,339 shares.
- A further direct disposal of 9,858 shares occurred on March 26, 2025, at $3.15, leaving 1,099,481 shares.
- On March 27, 2025, DSS, Inc. directly disposed of 47,681 shares at $2.5011, resulting in a holding of 1,051,800 shares.
- The report indicates both direct and indirect ownership changes, with transactions executed at varying prices.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the reduction in DSS, Inc.'s stake in Impact Biomedical Inc., which could indicate a lack of confidence or a strategic shift.
Negatives
- DSS, Inc. has reduced its stake in Impact Biomedical Inc., which could be perceived negatively by investors.
Risks
- Continued selling pressure from DSS, Inc. could further depress the price of Impact Biomedical Inc. shares.
- The reasons behind DSS, Inc.'s selling activity are not disclosed, creating uncertainty for investors.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders and major shareholders. This filing indicates a change in ownership for Impact Biomedical Inc.
Stakeholder Impact
- Shareholders of Impact Biomedical Inc. may react negatively to the news of DSS, Inc. reducing its stake.
- The reduced ownership stake of DSS, Inc. could impact investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03/21/2025 | Indirect disposal of common stock through DSS Securities, Inc., DSS BlockChain Security, Inc., and DSS BioHealth Security, Inc. |
| 03/26/2025 | Direct disposal of common stock. |
| 03/27/2025 | Direct disposal of common stock. |
| 03/28/2025 | Date of signature for the report. |
Keywords
Impact Biomedical Inc., DSS, Inc., share disposal, beneficial ownership, Form 4, IBO, stock sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.